ATLASAptevo Therapeutics (APVO) earnings date: Nov 5, 2026
Aptevo Therapeutics (APVO) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026. Analysts expect EPS of -$3.72.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on APVO
| Last price | $1.34 (-1.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.3% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Aptevo Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Aptevo Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Aptevo Therapeutics. You can switch it off at any time.
Alert me before APVO reportsFree to start. Creating an account takes under a minute.
Notify me when Aptevo Therapeutics reports
APVO earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$3.72 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +8.3% |
| Average move around a report | ±7.8% (last 5) |
| Sector | Healthcare · Biotechnology |
Aptevo Therapeutics earnings history: last 5 reports
Aptevo Therapeutics last reported on Aug 14, 2026: EPS of -$5.31 against an estimate of -$6.20 (+14.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$6.20 | -$5.31 | +14.4% | Beat | -17.4% |
| May 13, 2026 | -$5.60 | -$6.41 | -14.5% | Miss | -0.7% |
| Nov 21, 2025 | -$0.29 | -$0.41 | -41.4% | Miss | +9.3% |
| Nov 6, 2025 | -$37.62 | -$40.14 | -6.7% | Miss | +2.8% |
| Aug 11, 2025 | -$1,497.60 | -$151.20 | +89.9% | Beat | -8.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for APVO
See the fair value, the probability range and the earnings history of Aptevo Therapeutics on its ATLAS page.
Aptevo Therapeutics (APVO) stock analysisPlans from €3.99 a month.
Aptevo Therapeutics earnings: frequently asked questions
When does Aptevo Therapeutics (APVO) report earnings?
Aptevo Therapeutics is scheduled to report on Thursday, November 5, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for APVO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$3.72 per share (USD). Estimates can change before the report.
How often does APVO beat earnings estimates?
Of its last 5 reports with a recorded result, Aptevo Therapeutics beat the EPS estimate 2 times; the average surprise was +8.3%. Past results do not predict the next one.
How much does APVO move around earnings?
Over its last 5 reports the stock moved an average of 7.8% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Aptevo Therapeutics beat earnings estimates last quarter?
Aptevo Therapeutics last reported on Aug 14, 2026: EPS of -$5.31 against an estimate of -$6.20 (+14.4% surprise), a beat.
How much does APVO usually move in a day?
On a normal trading day the ATLAS model puts APVO’s one-day range at about ±5.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer